These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3586701)

  • 1. The plantar nerves-lumbrical muscles: a useful nerve-muscle preparation for assaying the effects of botulinum neurotoxin.
    Clark AW; Bandyopadhyay S; DasGupta BR
    J Neurosci Methods; 1987 Apr; 19(4):285-95. PubMed ID: 3586701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A: kinetics of calcium dependent paralysis of the neuromuscular junction and antagonism by drugs and animal toxins.
    Metezeau P; Desban M
    Toxicon; 1982; 20(3):649-54. PubMed ID: 6125045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of botulinum neurotoxin types A and E at the rat neuromuscular junction.
    Sellin LC; Kauffman JA; Dasgupta BR
    Med Biol; 1983 Apr; 61(2):120-5. PubMed ID: 6308364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction.
    Duregotti E; Zanetti G; Scorzeto M; Megighian A; Montecucco C; Pirazzini M; Rigoni M
    Toxins (Basel); 2015 Dec; 7(12):5322-36. PubMed ID: 26670253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of the chick ciliary ganglion-iris neuromuscular preparation to botulinum neurotoxin.
    Lomneth R; Suszkiw JB; DasGupta BR
    Neurosci Lett; 1990 May; 113(2):211-6. PubMed ID: 2165581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
    Simpson LL
    Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
    Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
    Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins.
    Angaut-Petit D; Molgo J; Connold AL; Faille L
    Neurosci Lett; 1987 Nov; 82(1):83-8. PubMed ID: 2962016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin serotype D is poorly effective in humans: an in vivo electrophysiological study.
    Eleopra R; Montecucco C; Devigili G; Lettieri C; Rinaldo S; Verriello L; Pirazzini M; Caccin P; Rossetto O
    Clin Neurophysiol; 2013 May; 124(5):999-1004. PubMed ID: 23245668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Janus faces of botulinum neurotoxin: sensational medicine and deadly biological weapon.
    Osborne SL; Latham CF; Wen PJ; Cavaignac S; Fanning J; Foran PG; Meunier FA
    J Neurosci Res; 2007 May; 85(6):1149-58. PubMed ID: 17387703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sprouting of frog motor nerve terminals after long-term paralysis by botulinum type A toxin.
    Diaz J; Molgó J; Pécot-Dechavassine M
    Neurosci Lett; 1989 Jan; 96(2):127-32. PubMed ID: 2784552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.
    Bandyopadhyay S; Clark AW; DasGupta BR; Sathyamoorthy V
    J Biol Chem; 1987 Feb; 262(6):2660-3. PubMed ID: 3029090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction between divalent cations and botulinum toxin type A in the paralysis of the rat phrenic nerve-hemidiaphragm preparation.
    Simpson LL
    Neuropharmacology; 1973 Feb; 12(2):165-76. PubMed ID: 4362622
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of the presynaptic actions of botulinum toxin and beta-bungarotoxin on neuromuscular transmission.
    Chang CC; Huang MC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):129-42. PubMed ID: 4368526
    [No Abstract]   [Full Text] [Related]  

  • 15. An electron microscopic study of the changes induced by botulinum toxin in the motor end-plates of slow and fast skeletal muscle fibres of the mouse.
    Duchen LW
    J Neurol Sci; 1971 Sep; 14(1):47-60. PubMed ID: 5119451
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum neurotoxin: the neuromuscular junction revisited.
    Coffield JA
    Crit Rev Neurobiol; 2003; 15(3-4):175-96. PubMed ID: 15248810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light chain of botulinum neurotoxin is active in mammalian motor nerve terminals when delivered via liposomes.
    de Paiva A; Dolly JO
    FEBS Lett; 1990 Dec; 277(1-2):171-4. PubMed ID: 2176612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin: the ugly duckling.
    Koussoulakos S
    Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the constituent chains of botulinum neurotoxins A and B in the blockade of neurotransmitter release.
    Maisey EA; Wadsworth JD; Poulain B; Shone CC; Melling J; Gibbs P; Tauc L; Dolly JO
    Eur J Biochem; 1988 Nov; 177(3):683-91. PubMed ID: 3197726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum neurotoxins.
    Rossetto O; Megighian A; Scorzeto M; Montecucco C
    Toxicon; 2013 Jun; 67():31-6. PubMed ID: 23435262
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.